T1	Participants 75 113	patients with cancer of the esophagus.
T2	Participants 951 1078	121 patients demonstrated a significant advantage for survival in the patients who received chemotherapy and radiation therapy.
T3	Participants 1465 1542	Seven patients in the radiotherapy group and 25 in the combined-therapy group
